Literature DB >> 19294883

Meta-analysis of the ACE gene polymorphism in cerebral infarction.

Hong-miao Tao1, Bei Shao, Guo-zhong Chen.   

Abstract

BACKGROUND: The angiotensin-1 converting enzyme (ACE) gene is known to have two polymorphic alleles insertion/deletion (I/D). People with the DD genotype have been shown to be at greater risk of cerebral infarction, but only in some studies. Identification of cerebral infarction susceptibility genes and quantification of associated risks have been hampered by conflicting results from underpowered case-control studies. This meta-analysis was made to look specifically into the genetics of cerebral infarction among Han Chinese population.
METHODS: Genetic associations studies published from January 1, 1990 to December 30, 2007 were collected from databases of MEDLINE, EMBASE, CBM and CNKI. Data were extracted using standardised forms and pooled odds ratios (ORs) with 95% confidence intervals (CIs) were calculated.
RESULTS: Twenty-nine original case-control studies of Han Chinese population, comprising 3654 patients with cerebral infarction and 3058 controls were included in the meta-analysis. Using the random effects model, the pooled ORs of ACE DD genotype VS ID+ II was 1.91 (95% CI 1.56 to 2.34, P<0.00001).
CONCLUSIONS: These data suggest that the ACE DD genotype may be a risk factor for cerebral infarction in Han Chinese population. A large scale case-control study is needed to clarify the functional effect of the polymorphism of the ACE I/D gene in the pathogenesis of cerebral infarction in Han Chinese population.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19294883     DOI: 10.1017/s0317167100006259

Source DB:  PubMed          Journal:  Can J Neurol Sci        ISSN: 0317-1671            Impact factor:   2.104


  7 in total

1.  Paediatric acute basilar thrombosis successfully treated with intravenous alteplase.

Authors:  Paulo Rego Sousa; Rui Vasconcellos
Journal:  BMJ Case Rep       Date:  2012-05-08

2.  Implications of the angiotensin converting enzyme gene insertion/deletion polymorphism in health and disease: a snapshot review.

Authors:  Paul R Gard
Journal:  Int J Mol Epidemiol Genet       Date:  2010-03-20

3.  Pharmacogenomics Informs Cardiovascular Pharmacotherapy.

Authors:  Mariana Babayeva; Brigitte Azzi; Zvi G Loewy
Journal:  Methods Mol Biol       Date:  2022

4.  Detailed analysis of gene polymorphisms associated with ischemic stroke in South Asians.

Authors:  Sunaina Yadav; Nazeeha Hasan; Thomas Marjot; Muhammad S Khan; Kameshwar Prasad; Paul Bentley; Pankaj Sharma
Journal:  PLoS One       Date:  2013-03-07       Impact factor: 3.240

5.  Association between Insertion/Deletion Polymorphism in Angiotension Converting Enzyme and Susceptibility to Schizophrenia.

Authors:  Hajar Mazaheri; Mostafa Saadat
Journal:  Iran J Public Health       Date:  2015-03       Impact factor: 1.429

6.  Top Three Pharmacogenomics and Personalized Medicine Applications at the Nexus of Renal Pathophysiology and Cardiovascular Medicine.

Authors:  Murielle Bochud; Michel Burnier; Idris Guessous
Journal:  Curr Pharmacogenomics Person Med       Date:  2011-12

7.  Angiotensin I - Converting Enzyme Gene Polymorphism and Activity in Patients with Ischemic Stroke.

Authors:  Sanja Stankovic; Aleksandra Stankovic; Milika Asanin; Zagorka Jovanovic-Markovic; Dragan Alavantic; Nada Majkic-Singh
Journal:  EJIFCC       Date:  2011-01-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.